WITHDRAWAL SYNDROMES TREATMENTS |
|
|
Pharmacologic and medical management is
often recommended for withdrawal syndrome. The physical condition of
the patient is closely monitored throughout the detoxification
procedure.
Alcohol withdrawal
Alcohol withdrawal syndrome can be treated at home or in a hospital
or treatment setting. Inpatient treatment is recommended for
patients who are at risk for serious withdrawal symptoms or re-intoxication
if treated as an outpatient. Withdrawal symptoms are minimized
through the administration of cross-tolerant sedatives. Long-acting
benzodiazepines, such as diazepam (Valium), chlordiazepoxide (Librium),
and lorazepam (Ativan), are the pharmacologic treatment of choice in
managing the symptoms of alcohol withdrawal. Drug dosage is adjusted
to offset the discomfort of withdrawal, without causing a euphoric
effect, and is then gradually decreased as withdrawal symptoms
lessen.
Barbiturate withdrawal
Because the risk for seizures and other severe complications is high,
barbiturate withdrawal should be monitored in a hospital setting.
Patients are given low doses of phenobarbital at a regular interval
until mild intoxication is achieved. The dosage amount and frequency
is then gradually decreased until withdrawal is complete.
Opiate withdrawal
Two basic treatment approaches are used for managing opiate
withdrawal. The first involves treating the symptoms of the
withdrawal with appropriate medication. Clondine, an
antihypertensive drug, is commonly prescribed to reduce muscle pain
and cramping. Other symptom-specific drugs are administered on an
as-needed basis.
The second treatment option is to replace the patient's drug of
choice with methadone, a long-acting, cross-tolerant opiate that
does not normally produce a "high." Doses of methadone are
administered every four to six hours. The patient's reaction is
closely observed, and dosages are slowly decreased until withdrawal
symptoms have disappeared, and dosages are then discontinued.
Methadone withdrawal can be completed within three weeks. It is
important to note that methadone withdrawal treatment differs from a
methadone maintenance program, in which patients who are unwilling
to give up opiates are prescribed methadone as a legal, long-term
substitute for their drug of choice.
Rapid opiate detoxification (ROD) is an emerging treatment option
for opiate withdrawal. The ROD method is reported to be faster and
to cause less physical discomfort than traditional forms of opiate
detoxification. The treatment is typically performed in a hospital
or private clinic setting. Naltrexone, an opiate antagonistic that
blocks opiate receptors and reverses the effects of opiates, is
administered to trigger the withdrawal response. Clonidine is given
simultaneously to ease the symptoms of withdrawal. The patient is
anesthetized throughout the three to four hour procedure, and
withdrawal occurs while the patient sleeps. Vital signs are
monitored closely and a ventilator may be employed.
Stimulant withdrawal
Because of the depression and dysphoria (feeling of a psychological
low) related to stimulant withdrawal, psychological and/or medical
management is critical. Treatment may include a regimen of drugs
that increase neurotransmitter production. |
|
|
| WITHDRAWAL SYNDROMES RELATED ITEMS |
|
|
|
|